Hamilton S E, Pitts A E, Katipally R R, Jia X, Rutter J P, Davies B A, Shay J W, Wright W E, Corey D R
Department of Pharmacology, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75235, USA.
Biochemistry. 1997 Sep 30;36(39):11873-80. doi: 10.1021/bi970438k.
Telomerase is a ribonucleoprotein that participates in the maintenance of telomere length. Its activity is up-regulated in many tumor types, suggesting that it may be a novel target for chemotherapy. The RNA component of telomerase contains an active site that plays at least two roles&sbd;binding telomere ends and templating their replication [Greider, C. W., & Blackburn, E. H. (1989) Nature 337, 331-337]. The accessibility of RNA nucleotides for inhibitor binding cannot be assumed because of the potential for RNA secondary structure and RNA-protein interactions. Here we use high-affinity recognition by overlapping peptide nucleic acids (PNAs) [Nielsen, P. E., et al. (1991) Science 254, 1497-1500] to identify nucleotides within the RNA active site of telomerase that are determinants for inhibitor recognition. The IC50 for inhibition decreases from 30 microM to 10 nM as cytidines 50-52 (C50-52) at the boundary between the alignment and elongation domains are recognized by PNAs overlapping from the 5' direction. As C50-52 are uncovered in the 3' direction, IC50 increases from 10 nM to 300 nM. As cytidine 56 at the extreme 3' end of the active site is uncovered, IC50 values increase from 0.5 microM to 10 microM. This analysis demonstrates that C50-C52 and C56 are important for PNA recognition and are physically accessible for inhibitor binding. We use identification of these key determinants to minimize the size of PNA inhibitors, and knowledge of these determinants should facilitate design of other small molecules capable of targeting telomerase. The striking differences in IC50 values for inhibition of telomerase activity by related PNAs emphasize the potential of PNAs to be sensitive probes for mapping complex nucleic acids. We also find that PNA hybridization is sensitive to nearest-neighbor interactions, and that consecutive guanine bases within a PNA strand increase binding to complementary DNA and RNA sequences.
端粒酶是一种核糖核蛋白,参与端粒长度的维持。其活性在许多肿瘤类型中上调,这表明它可能是化疗的一个新靶点。端粒酶的RNA组分含有一个活性位点,该位点至少发挥两个作用——结合端粒末端并为其复制提供模板[Greider, C. W., & Blackburn, E. H. (1989) Nature 337, 331 - 337]。由于RNA二级结构和RNA - 蛋白质相互作用的可能性,不能假定RNA核苷酸可用于抑制剂结合。在这里,我们利用重叠肽核酸(PNA)的高亲和力识别[Nielsen, P. E., et al. (1991) Science 254, 1497 - 1500]来鉴定端粒酶RNA活性位点内作为抑制剂识别决定因素的核苷酸。当在比对和延伸结构域之间的边界处的胞嘧啶50 - 52(C50 - 52)被从5'方向重叠的PNA识别时,抑制的IC50从30 μM降至10 nM。当C50 - 52从3'方向被暴露时,IC50从10 nM增加到300 nM。当活性位点最3'端的胞嘧啶56被暴露时,IC50值从0.5 μM增加到10 μM。该分析表明C50 - C52和C56对于PNA识别很重要,并且在物理上可用于抑制剂结合。我们利用这些关键决定因素的鉴定来最小化PNA抑制剂的大小,并且对这些决定因素的了解应该有助于设计其他能够靶向端粒酶的小分子。相关PNA抑制端粒酶活性的IC50值的显著差异强调了PNA作为绘制复杂核酸的敏感探针的潜力。我们还发现PNA杂交对相邻碱基相互作用敏感,并且PNA链内连续的鸟嘌呤碱基增加与互补DNA和RNA序列的结合。